Holger Liepmann

Holger Liepmann

Chairman at
F3 Platform Biologics, Inc.
74 year
Health Technology
Consumer Services
Commercial Services

Profile

Holger A. Liepmann is currently the Chairman of F3 Platform Biologics, Inc. and a Director at PanTheryx, Inc., Desert Research Institute Foundation, and SmartTots.
He previously held positions as Chairman at Abbott GmbH (Germany), Director at Verenium Corp., Enzymotec Ltd., and Altan Pharma Ltd., and Executive Vice President at Abbott Laboratories and Pharmaceutical Products.
He was also a Senior Vice President at Abbott International LLC and a Marketing Manager-Europe at Cutter Laboratories, Inc. Liepmann received his undergraduate degree from Dartmouth College and his MBA from Stanford University.

Holger Liepmann active positions

CompaniesPositionStart
Director/Board Member -
SmartTots
Director/Board Member -
Director/Board Member 09/04/2020
Chairman -

Former positions of Holger Liepmann

CompaniesPositionEnd
Chief Operating Officer 01/01/2021
VERENIUM CORP Director/Board Member 30/10/2013
Abbott International LLC
Corporate Officer/Principal 01/01/2011
ABBOTT LABORATORIES Corporate Officer/Principal 31/12/2010
Pharmaceutical Products
Corporate Officer/Principal -
See the detail of Holger Liepmann's experience

Training of Holger Liepmann

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

94

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Pharmaceutical Products

Commercial Services

Health Technology

Abbott International LLC

Cutter Laboratories, Inc.

Health Technology

SmartTots

Health Technology

  1. Stock Market
  2. Insiders
  3. Holger Liepmann